http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2335662-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
filingDate 1994-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0756d4f0dc0e18d8cef94066c633d61f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a8bceed6b8f38e8f4c1e8fc021d9048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a09de83514b9d0796ff36d0aba638d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c8b44ce241eb695c25c50919217859
publicationDate 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2335662-T3
titleOfInvention TREATMENT OF NEUROMUSCULAR DISORDERS AND AFFECTIONS WITH DIFFERENT BOTULINUM SEROTYPES.
abstract Use of botulinum toxin type B for the manufacture of a medicament for the treatment of neuromuscular disorders, in which botulinum toxin type B is administered to a patient until the patient develops neutralizing antibodies, after which a botulinum toxin is administered Type A, C, D, E or F.
priorityDate 1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1542
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85165
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30426
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1561
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04958
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1492
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1542
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1561
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86643
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1492

Total number of triples: 70.